NCT04459429 is a NA clinical trial of Change of cannula size in RDS - Infants, sponsored by Erebouni Medical Center.

Who is sponsoring NCT04459429?

NCT04459429 is sponsored by Erebouni Medical Center.

What drugs are being tested in NCT04459429?

Interventions in NCT04459429: Change of cannula size.

What condition does NCT04459429 study?

NCT04459429 studies RDS - Infants, TTN.

Is NCT04459429 still recruiting?

NCT04459429 is currently completed. Last updated 30 June 2021.

Last reviewed 2021-06-30 · How we verify

NCT04459429

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Cannula Size on Oxygen Saturation During Nasal High Flow Therapy in Newborns

Completed NA Last updated 30 June 2021

What this trial tests

NA trial testing Change of cannula size in RDS - Infants in 25 participants. Completed in 24 December 2020.

Timeline

26 June 2020

Primary endpoint
24 December 2020

24 December 2020

Quick facts

Lead sponsor	Erebouni Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	25
Start date	26 June 2020
Primary completion	24 December 2020
Estimated completion	24 December 2020
Sites	1 location across Armenia

Drugs / interventions tested

Change of cannula size

Conditions studied

RDS - Infants — all drugs for RDS - Infants →
TTN — all drugs for TTN →

Sponsor

Erebouni Medical Center

Who can join

Adults 1 Hour to 2 Days, any sex, with RDS - Infants or TTN. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Treatment with nasal high flow therapy (NHF) is an increasingly popular method of respiratory support in newborns. Safe and effective use of NHF requires selection of an appropriate nasal prong-to-nares ratio because leak can influence the delivered pressure. To the best of our knowledge, this is the first study to investigate the effect of using different NHF cannula size on peripheral oxygen saturation in newborns with respiratory distress.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Erebouni Medical Center trials

Trials by the same sponsor.

NCT05257369 — Broad Band Emission LED Phototherapy Source Versus Narrow Band · NA · unknown
NCT05036161 — ROX Index and ROX Vector to Predict Nasal High Flow / Continuous Positive Airway Pressure Failure in Neonates · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04459429 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Erebouni Medical Center
Last refreshed: 30 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04459429.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing